LEADER 01962nam  2200433   450 
001 9910707980503321
005 20170125100859.0
035   $a(CKB)5470000002468761
035   $a(OCoLC)969356665
035   $a(OCoLC)995470000002468761
035   $a(EXLCZ)995470000002468761
100   $a20170119d2016      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aDrug safety, FDA has improved its foreign drug inspection program, but needs to assess the effectiveness and staffing of its foreign offices : report to the Committee on Energy and Commerce
210  1$a[Washington, D.C.] :$cUnited States Government Accountability Office,$d2016.
215   $a1 online resource (iii, 57 pages) $ccolor illustrations, color map
300   $a"GAO-17-143."
300   $a"December 2016."
320   $aIncludes bibliographical references.
517   $aDrug safety, FDA has improved its foreign drug inspection program, but needs to assess the effectiveness and staffing of its foreign offices 
606   $aDrugs$xSafety measures$xEvaluation
606   $aPharmaceutical industry$xQuality control$xEvaluation
606   $aDrugs$xSafety regulations$xEvaluation
606   $aImports$xSafety measures$xEvaluation
615  0$aDrugs$xSafety measures$xEvaluation.
615  0$aPharmaceutical industry$xQuality control$xEvaluation.
615  0$aDrugs$xSafety regulations$xEvaluation.
615  0$aImports$xSafety measures$xEvaluation.
712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Energy and Commerce,
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910707980503321
996   $aDrug safety, FDA has improved its foreign drug inspection program, but needs to assess the effectiveness and staffing of its foreign offices : report to the Committee on Energy and Commerce$93251271
997   $aUNINA